We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

11 hedge funds and large institutions have $15.9M invested in NewAmsterdam Pharma Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more capital invested

Capital invested by funds: $5.65M → $15.9M (+$10.2M)

0.26% less ownership

Funds ownership: 2.01% → 1.74% (-0.26%)

39% less funds holding

Funds holding: 18 → 11 (-7)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
11
Holders Change
-7
Holders Change %
-38.89%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
10
Calls
$828K
Puts
–
Net Calls
+$828K
Net Calls Change
+$593K

Top Buyers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
+$1.1M
2
AAA
Affinity Asset Advisors
New York
+$597K
3
MIM
Monashee Investment Management
Massachusetts
+$284K
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$9.1K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$745K
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$470K
3
ACM
ADAR1 Capital Management
Texas
-$259K
4
WCMNY
Westchester Capital Management (New York)
New York
-$97.6K
5
Walleye Capital
Walleye Capital
New York
-$70.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$5.52M – – –
RCM
2
RA Capital Management
Massachusetts
$3.68M – – –
AAA
3
Affinity Asset Advisors
New York
$2.24M +$597K +65,599 +48%
GS
4
GTS Securities
New York
$1.34M +$1.1M +121,150 New
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$1.1M – – –
DM
6
Deerfield Management
New York
$1.02M – – –
MIM
7
Monashee Investment Management
Massachusetts
$344K +$284K +31,189 New
HF
8
HRT Financial
New York
$334K – – –
LCM
9
Laurion Capital Management
New York
$184K – – –
VI
10
Vestcor Inc
New Brunswick, Canada
$106K – – –
CIBC Private Wealth Group
11
CIBC Private Wealth Group
Georgia
$11.3K +$9.1K +1,000 New
Ensign Peak Advisors
12
Ensign Peak Advisors
Utah
– -$470K -150,000 Closed
ACM
13
ADAR1 Capital Management
Texas
– -$259K -82,857 Closed
EC
14
EcoR1 Capital
California
– -$745K -66,665 Closed
WCMNY
15
Westchester Capital Management (New York)
New York
– -$97.6K -31,189 Closed
Walleye Capital
16
Walleye Capital
New York
– -$70.9K -22,658 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$57.3K -18,319 Closed
PI
18
PEAK6 Investments
Illinois
– -$53.2K -17,000 Closed
Walleye Trading
19
Walleye Trading
New York
– -$41K -13,084 Closed
CS
20
Clear Street
New York
– -$28.1K -8,993 Closed
CG
21
Cutler Group
California
– -$15K -4,960 Closed

NAMSW Hedge Fund Activity: Q1 2024 in Review

11 of the 6,944 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q1 2024, worth a combined $15.9M — up 181% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of NAMSW and 3 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was GTS Securities, opening a new position worth an estimated $1.1M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $745K sold.

  • 11 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q1 2024, down from 18 in Q4 2023.
  • Funds reported $15.9M of NewAmsterdam Pharma Warrant stock for Q1 2024, up 181% quarter-over-quarter.
  • 3 funds opened new NewAmsterdam Pharma Warrant positions in Q1 2024 and 10 closed out, a net change of -7 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q1 2024 was GTS Securities, an estimated $1.1M added.
  • The largest NewAmsterdam Pharma Warrant seller in Q1 2024 was EcoR1 Capital, an estimated $745K sold.

Based on aggregated 13F filings for Q1 2024.